SEC Form 4 · accession 0001437749-18-013907
LIFECORE BIOMEDICAL, INC. \DE\ · LFCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory S Skinner
Officer — VP Finance and Admin & CFO
Period of report
Jul 25, 2018
Accepted (ET)
Jul 27, 2018 · 4:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005286
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Right to Buy Restricted Stock Unit (RSU)F1,F2 | — | Jul 25, 2018 | M | 6,183 | A | — | Jul 25, 2021 | Common Stock | 6,183 | 6,183 | D |
| Right to Buy Restricted Stock Unit (RSU)F1,F3 | — | Jul 25, 2018 | M | 9,930 | A | — | Jul 25, 2021 | Common Stock | 9,930 | 9,930 | D |
| Nonqualified Stock Option (Right to Buy) | $14.35 | Jul 25, 2018 | M | 12,321 | A | Jul 25, 2021 | Jul 25, 2025 | Common Stock | 12,321 | 108,321 | D |
| Incentive Stock Option (Right to Buy) | $14.35 | Jul 25, 2018 | M | 6,229 | A | Jul 25, 2021 | Jul 25, 2025 | Common Stock | 6,229 | 114,550 | D |
Explanation of responses
- F1The Restricted Stock Units convert into Common Stock of Landec Corporation on a 1 for 1 basis.
- F2Restricted Stock Units will vest on the 3rd anniversary of the grant date and will be automatically settled in shares of common stock subject to vesting at a rate of 1 share per unit.
- F3Restricted Stock Units will be automatically settled in shares of common stock subject to achievement of the performance goals set forth in the Company's LTIP for 2021.